Coherus Oncology Statistics
NASDAQ: CHRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.01-0.02 (-1.94%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 1.00 -0.99%
Coherus Oncology by the numbers
Coherus Oncology has a market capitalization of $156.0 million based on 154.50M shares outstanding. With trailing EPS of $-1.25, Coherus Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.6% below its 50-day average and 35.6% below its 200-day average.
Average daily trading volume is 1.14M shares, or about $1.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CHRS valuation vs. peer median
| Metric | CHRS | Peer median | Difference |
|---|---|---|---|
| Market cap | $156.05M | $152.63M | +2% |
| Avg. volume | 1.14M | 497.90K | +130% |
Peer median across 8 companies: CRDL, TARA, VYGR, ABOS, IPHA, MOLN, DTIL, OTLK.
Valuation
- Market cap
- $156.05M
- EPS (TTM)
- $-1.25
- Shares outstanding
- 154.50M
Price and trading
- Previous close
- 1.03
- Open
- 1.02
- Day range
- 1.01 – 1.08
- 52-week range
- 1.01 – 2.62
- 52-week change
- -40.94%
- Beta
- —
- Volume
- 1.23M
- Average volume
- 1.14M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 156.05M
- Forward Pe
- -1.60
- Eps
- -1.25
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.62
- Week52 Low
- 1.01
- Avg Volume
- 1.14M
- Shares Outstanding
- 154.50M
- Ma50
- 1.31
- Ma200
- 1.57
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -61.39%
- Pct From52w Low
- 0.00%